Back to top
Top
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

All eCQMs associated with: Process

Year CMS eCQM ID Measure Name
2024 CMS138v12 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
2025 CMS138v13 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
2022 CMS139v10 Falls: Screening for Future Fall Risk
2023 CMS139v11 Falls: Screening for Future Fall Risk
2024 CMS139v12 Falls: Screening for Future Fall Risk
2025 CMS139v13 Falls: Screening for Future Fall Risk
2022 CMS142v10 Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
2023 CMS142v11 Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
2024 CMS142v12 Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
2025 CMS142v13 Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
2022 CMS143v10 Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
2023 CMS143v11 Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
2024 CMS143v12 Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
2025 CMS143v13 Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
2022 CMS144v10 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2023 CMS144v11 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2024 CMS144v12 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2025 CMS144v13 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2022 CMS145v10 Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than 40%)
2023 CMS145v11 Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than or equal to 40%)

We want your feedback

Feedback pertains to:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.